Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 58 filings·Updated 30 Sept 2026
Showing 10 of 58 filings.
30 Sept 20261 filing
Company UpdateCredit Rating

CARE reaffirms long-term rating and upgrades LT/ST facilities for Corona Remedies Ltd; Stable outlook.

Rating Details

  • Long Term Bank Facilities ₹7.00 cr: CARE A+; Stable; Reaffirmed.
  • Long Term / Short Term Bank Facilities ₹70.00 cr: CARE A+; Stable / CARE A1+; Upgraded.
  • Material change since last rating: LT facility reaffirmed; LT/ST upgraded.
  • Outlook: Stable.
  • Rationale: Based on FY26 audited and Q1FY27 unaudited performance.
  • Rating Agency: CARE Ratings Limited.
  • Surveillance may occur; annual review.
Filed 19:16View Source
28 Sept 20261 filing
Insider Trading / SASTClosure of Trading Window

CORONA Remedies Limited: Trading Window closed from October 01, 2026 until 48 hours from the declaration of the unaudited financial results for the second quarter and half year ending on September 30, 2026

CORONA Remedies Limited: Trading Window closed from October 01, 2026 until 48 hours from the declaration of the unaudited financial results for the second quarter and half year ending on September 30, 2026

Filed 16:57View Source
19 Sept 20262 filings
Insider Trading / SASTDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Sepia Investments, Sage Investment Trust and Anchor Partners sell Corona Remedies shares in NSE open market

Transaction details

  • Target company: Corona Remedies Limited.
  • Disclosing party: Sepia Investments Limited; Sage Investment Trust; Anchor Partners (non-promoter group).
  • Before disposal, Sepia Investments Limited held 7,755,786 shares (12.68%).
  • Before disposal, Sage Investment Trust held 161,400 shares (0.26%).
  • Before disposal, Anchor Partners held 289,992 shares (0.47%).
  • Sepia sold 2,485,476 shares (4.06%).
  • Sage Investment Trust sold 51,641 shares (0.08%).
  • Anchor Partners sold 92,763 shares (0.15%).
  • Post-disposal, Sepia holds 5,270,310 shares (8.62%).
  • Post-disposal, Sage holds 109,759 shares (0.18%).
  • Post-disposal, Anchor holds 197,229 shares (0.32%).
  • Mode of sale: open market on NSE.
  • Date of sale: 10 September 2026.
  • Pre-disposal equity capital: INR 611,600,880 (6,11,60,088 shares).
  • Post-disposal equity capital: INR 611,600,880 (6,11,60,088 shares).
  • Total diluted capital after sale: INR 611,600,880 (6,11,60,088 shares).
Filed 15:42View Source
Insider Trading / SASTDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Corona Remedies Ltd: Concerted sale of equity shares by three sellers on NSE on 10 September 2026

Transaction details (SAST Reg 29(2))

  • Target: Corona Remedies Limited.
  • Transaction type: disposal of shares.
  • Sellers: Sepia Investments Limited; Sage Investment Trust; Anchor Partners (acting in concert).
  • Sepia pre-disposal holding: 7,755,786 shares (12.68%).
  • Sage pre-disposal holding: 161,400 shares (0.26%).
  • Anchor pre-disposal holding: 289,992 shares (0.47%).
  • Sepia disposal: 2,485,476 shares (4.06%).
  • Sage disposal: 51,641 shares (0.08%).
  • Anchor disposal: 92,763 shares (0.15%).
  • Sepia post-disposal holding: 5,270,310 shares (8.62%).
  • Sage post-disposal holding: 109,759 shares (0.18%).
  • Anchor post-disposal holding: 197,229 shares (0.32%).
  • Mode: open market sale on NSE; Date: 10 September 2026.
  • Equity share capital before/after: INR 611,600,880 (6,11,60,088 shares).
  • Total diluted share/voting capital after sale: INR 611,600,880 (6,11,60,088 shares).
Filed 15:14View Source
18 Sept 20261 filing
Company UpdateAnalyst / Investor Meet

Corona Remedies schedules group investor meet with JP Morgan on Sept 23, 2026 in Ahmedabad

Meeting Details

  • Date and time: Wednesday, September 23, 2026, at 2:00 pm.
  • Type and mode: Group meeting, in-person in Ahmedabad.
  • Organizer: JP Morgan.
  • Place: Ahmedabad.

Participants

  • Key company participants: Company officials (roles not specified).

Purpose

  • Purpose: Investor interactions based on publicly available information.

Additional Notes

  • Intimation also available on the company's website.
Filed 14:56View Source
10 Sept 20262 filings
Company UpdateGeneral

Corona Remedies clarifies that share volume rise is market-driven, no undisclosed information

Volume movement clarification

  • Volume increase is market-driven with no undisclosed or price-sensitive information.
  • Company confirms ongoing compliance with Listing Regulations and timely disclosures to exchanges.
  • No impending corporate action or material announcements at this time.
Filed 12:08View Source
Company UpdateClarification

The Exchange has sought clarification from Corona Remedies Ltd on September 10, 2026, with reference to Movement in Volume. <BR><BR>The reply is awaited.

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 11:08
9 Sept 20262 filings
Company UpdateSpurt in Volume

Significant increase in volume has been observed in CORONA Remedies Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. CORONA Remedies Limited has submitted their response.

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 20:36View Source
Company UpdateSpurt in Volume

Significant increase in volume has been observed in CORONA Remedies Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 17:52View Source
20 Aug 20261 filing
Company UpdateAnalyst / Investor Meet

Corona Remedies to participate in in-person investor conference hosted by Phillip Capital PCG on Aug 26, 2026

Meeting Details

  • Date/time: Wed, Aug 26, 2026, 11:00 AM IST onwards.
  • Group meeting; In-person participation.
  • Organized by Phillip Capital PCG.
  • Venue: Ahmedabad.

Participants

  • Key participants: Company officials (roles not specified).

Purpose

  • Purpose: Participation in Analyst/Investor Conference; discussions based on publicly available information; UPSI not discussed.
Filed 17:18View Source
Showing 10 of 58 filings